Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Molecular Cancer Research : MCR|April 1, 2010
TAF4b and Jun/activating protein-1 collaborate to regulate the expression of integrin alpha6 and cancer cell migration propertiesMargarita Kalogeropoulou, Angeliki Voulgari, Vassiliki Kostourou, et al.Scientific Reports|November 10, 2016
Death receptor 5 (DR5) and a 5-gene apoptotic biomarker panel with significant differential diagnostic potential in colorectal cancerMarina Devetzi, Vivian Kosmidou, Margarita Vlassi, et al.Oncotarget|January 24, 2016
BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cellsMaria Goulielmaki, Evangelos Koustas, Eirini Moysidou, et al.Cancer Investigation|November 4, 2009
Gene expression profile associated with oncogenic ras-induced senescence, cell death, and transforming properties in human cellsSophy S Moumtzi, Michael L Roberts, Tobias Joyce, et al.International Journal of Cancer|July 29, 2009
TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumorsEftychia Oikonomou, Vivian Kosmidou, Anastasia Katseli, et al.Molecular and Cellular Neurosciences|March 23, 2010
The expression of ELK transcription factors in adult DRG: Novel isoforms, antisense transcripts and upregulation by nerve damageNiall Kerr, Alexander Pintzas, Fiona Holmes, et al.Human Mutation|December 20, 2013
Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implicationsVivian Kosmidou, Eftychia Oikonomou, Margarita Vlassi, et al.European Journal of Clinical Investigation|July 19, 2020
Noxa upregulation and 5-gene apoptotic biomarker panel in colorectal cancerVivian Kosmidou, Margarita Vlassi, Kyriakos Anagiotos, et al.Anticancer Research|May 30, 2008
Culture of primary epithelial adenoma cells from familial adenomatous polyposis patientsFlorentia Fostira, Angela Apessos, Eutyxia Oikonomou, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 1, 2021
BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600Ε CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysisKassandra Koumaki, Georgia Kontogianni, Vivian Kosmidou, et al.Pageof 4